CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 196 enrolled
Drug / intervention
No intervention, this is an observational studyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03063398
NCT03063398N/ACompleted
CompareCT.gov

PAPPEI: Post Acute Pancreatitis Pancreatic Exocrine Insufficiency

Ohio State University·observational·Posted Feb 24, 2017·Updated Jul 16, 2024

In Brief

An observational study evaluating No intervention, this is an observational study for Acute Pancreatitis. Completed, enrolled 196 participants across 3 sites.

Detailed Summary

This study is a proposed a comprehensive prospective assessment of exocrine pancreatic insufficiency (EPI), nutritional status, and quality of life (QOL) during the early re-feeding phase, at 3 months, and 12 months following an AP attack.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Pancreatitis
CountriesUnited States
CollaboratorsAbbVie

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 24, 2017
Enrollment StartJun 21, 2017
Primary CompletionFeb 1, 2023
Study CompletionJun 30, 2024
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 9.4 years ago

Interventions

No intervention, this is an observational studyother

Assessment for exocrine pancreatic insufficiency